Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$3.97
-0.30-7.07%
At close: -
$4.07
0.102.57%
After Hours: 6:42 PM EDT
Comments
Loading...
Mainz Biomed Analyst Ratings and Price Targets | NASDAQ:MYNZ | Benzinga
Mainz Biomed NV has a consensus price target of $12.5 based on the ratings of 4 analysts. The high is $14 issued by Maxim Group on February 14, 2025. The low is $11 issued by JonesTrading on February 10, 2023. The 3 most-recent analyst ratings were released by Maxim Group, HC Wainwright & Co., and HC Wainwright & Co. on February 14, 2025, March 6, 2024, and November 20, 2023, respectively. With an average price target of $7.33 between Maxim Group, HC Wainwright & Co., and HC Wainwright & Co., there's an implied 80.18% upside for Mainz Biomed NV from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Maxim Group
JonesTrading
1calculated from analyst ratings
Analyst Ratings for Mainz Biomed
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 02/14/2025 | Buy Now | 243.98% | Maxim Group | Michael Okunewitch25% | → $14 | Initiates | → Buy | Get Alert |
| 11/25/2024 | Buy Now | — | HC Wainwright & Co. | Yi Chen60% | — | Downgrade | Buy → Neutral | Get Alert |
| 04/12/2024 | Buy Now | — | Cantor Fitzgerald | Ross Osborn51% | — | Reiterates | → Neutral | Get Alert |
| 03/06/2024 | Buy Now | -26.29% | HC Wainwright & Co. | Yi Chen60% | $200 → $120 | Maintains | Buy | Get Alert |
| 11/21/2023 | Buy Now | — | Cantor Fitzgerald | Ross Osborn51% | — | Downgrade | Overweight → Neutral | Get Alert |
| 11/20/2023 | Buy Now | 22.85% | HC Wainwright & Co. | Yi Chen60% | $360 → $200 | Maintains | Buy | Get Alert |
| 09/26/2023 | Buy Now | 121.13% | Cantor Fitzgerald | Ross Osborn51% | → $360 | Reiterates | Overweight → Overweight | Get Alert |
| 09/22/2023 | Buy Now | 121.13% | HC Wainwright & Co. | Yi Chen60% | $280 → $360 | Maintains | Buy | Get Alert |
| 09/14/2023 | Buy Now | 121.13% | Cantor Fitzgerald | Ross Osborn51% | → $360 | Reiterates | Overweight → Overweight | Get Alert |
| 08/22/2023 | Buy Now | 121.13% | Cantor Fitzgerald | Ross Osborn51% | → $360 | Reiterates | Overweight → Overweight | Get Alert |
| 08/18/2023 | Buy Now | 71.99% | HC Wainwright & Co. | Yi Chen60% | $400 → $280 | Reiterates | Buy → Buy | Get Alert |
| 06/01/2023 | Buy Now | 145.7% | HC Wainwright & Co. | Yi Chen60% | → $400 | Reiterates | → Buy | Get Alert |
| 05/18/2023 | Buy Now | 194.84% | Cantor Fitzgerald | Ross Osborn51% | $600 → $480 | Maintains | Overweight | Get Alert |
| 04/27/2023 | Buy Now | 145.7% | HC Wainwright & Co. | Yi Chen60% | $1000 → $400 | Maintains | Buy | Get Alert |
| 03/30/2023 | Buy Now | 514.25% | HC Wainwright & Co. | Yi Chen60% | → $1000 | Reiterates | → Buy | Get Alert |
| 02/16/2023 | Buy Now | 514.25% | HC Wainwright & Co. | Yi Chen60% | → $1000 | Reiterates | → Buy | Get Alert |
| 02/10/2023 | Buy Now | 170.27% | JonesTrading | Justin Walsh41% | → $440 | Initiates | → Buy | Get Alert |
| 10/25/2022 | Buy Now | 268.55% | Cantor Fitzgerald | Ross Osborn51% | → $600 | Initiates | → Overweight | Get Alert |
| 06/21/2022 | Buy Now | 514.25% | HC Wainwright & Co. | Yi Chen60% | → $1000 | Initiates | → Buy | Get Alert |
FAQ
What is the target price for Mainz Biomed (MYNZ) stock?
The latest price target for Mainz Biomed (NASDAQ:MYNZ) was reported by Maxim Group on February 14, 2025. The analyst firm set a price target for $14.00 expecting MYNZ to rise to within 12 months (a possible 243.98% upside). 3 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Mainz Biomed (MYNZ)?
The latest analyst rating for Mainz Biomed (NASDAQ:MYNZ) was provided by Maxim Group, and Mainz Biomed initiated their buy rating.
When was the last upgrade for Mainz Biomed (MYNZ)?
There is no last upgrade for Mainz Biomed
When was the last downgrade for Mainz Biomed (MYNZ)?
The last downgrade for Mainz Biomed NV happened on November 25, 2024 when HC Wainwright & Co. changed their price target from N/A to N/A for Mainz Biomed NV.
When is the next analyst rating going to be posted or updated for Mainz Biomed (MYNZ)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Mainz Biomed, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Mainz Biomed was filed on February 14, 2025 so you should expect the next rating to be made available sometime around February 14, 2026.
Is the Analyst Rating Mainz Biomed (MYNZ) correct?
While ratings are subjective and will change, the latest Mainz Biomed (MYNZ) rating was a initiated with a price target of $0.00 to $14.00. The current price Mainz Biomed (MYNZ) is trading at is $4.07, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.